Growth in the 340B Drug Pricing Program

Congressional Budget Office

No 60661, Reports from Congressional Budget Office

Abstract: The 340B Drug Pricing Program requires pharmaceutical manufacturers to sell outpatient prescription drugs to participating health care facilities at discounted prices. Facilities that participate in the 340B program are hospitals, clinics, and other providers of health care services as well as other organizations that purchase drugs, such as those affiliated with state and local governments.

JEL-codes: I11 I13 I18 (search for similar items in EconPapers)
Date: 2025-09-09
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.cbo.gov/system/files/2025-09/60661-340B-program.pdf (application/pdf)
Our link check indicates that this URL is bad, the error code is: 403 Forbidden

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cbo:report:60661

Access Statistics for this paper

More papers in Reports from Congressional Budget Office Contact information at EDIRC.
Bibliographic data for series maintained by ().